Skip to main content
. Author manuscript; available in PMC: 2025 Jan 26.
Published in final edited form as: Contemp Clin Trials. 2023 Mar 16;128:107162. doi: 10.1016/j.cct.2023.107162

Table 3. Clinical Trial Data vs HES APC data for the cardiovascular outcomes.

HES APC primary diagnosis only Diagnosis box 1−5
Clinical trial database only HES APC 1 only Both Clinical trial database only HES APC 1-5 only4 Both4
Heart Failure 3 10 4 1 59 6
Acute Coronary Syndrome (ACS) 3 7 8 1 122 10
Thromboembolic Stroke 3 71 8 2 91 9
Other arterial embolism 23 2 0 2 4 0
Venous Thromboembolism 7 4 7 4 17 10
Any event 18 30 27 10 101 35
1

One event is on CRF, with diagnosis “Other arterial embolism”.

2

One event is on CRF, diagnosis “Heart failure” (this event has both HF and ACS diagnoses within NHS boxes 1−5).

3

One event is on NHS, diagnosis “Stroke”.

4

Five events cover two diagnoses in NHS boxes 1−5, and are listed under both categories.

5

Three are not on a trial CRF − 2 events are ACS (box 1) and HF (box 2−5); 1 event has no diagnosis (box 1) and HF and arterial embolism (box 2−5).

6

1 on a trial CRF − 1 is HF on CRF, and HF (box 1) and ACS (box 2−5.)